Comment
. 2004 Sep;364(9438):934; author reply 935.
doi: 10.1016/S0140-6736(04)17014-1.
VALUE: analysis of results
- PMID: 15364182
- DOI: 10.1016/S0140-6736(04)17014-1
Item in Clipboard
Comment
VALUE: analysis of results
Lancet.
2004 Sep.
No abstract available
Comment on
-
Outcomes in hypertensive patients at high cardiovascular risk treated with regimens based on valsartan or amlodipine: the VALUE randomised trial.Lancet. 2004 Jun 19;363(9426):2022-31. doi: 10.1016/S0140-6736(04)16451-9. Lancet. 2004. PMID: 15207952 Clinical Trial.
Similar articles
-
Valsartan treatment of hypertension--does VALUE add value?Lancet. 2004 Jun 19;363(9426):2010-1. doi: 10.1016/S0140-6736(04)16484-2. Lancet. 2004. PMID: 15207946 No abstract available.
-
Aliskiren/valsartan (Valturna) for hypertension.Med Lett Drugs Ther. 2009 Nov 30;51(1326):94-5. Med Lett Drugs Ther. 2009. PMID: 20224524 Review. No abstract available.
-
[VALUE].Nihon Rinsho. 2006 Aug;64 Suppl 6:419-24. Nihon Rinsho. 2006. PMID: 16981573 Review. Japanese. No abstract available.
-
[Risk oriented therapy of hypertension. Lowering blood pressure and risk].MMW Fortschr Med. 2007 Nov 15;149(46):53. MMW Fortschr Med. 2007. PMID: 18069196 German. No abstract available.
-
Hope in Life and Value of blood pressure control.J Hypertens. 2004 Dec;22(12):2265-6. doi: 10.1097/00004872-200412000-00005. J Hypertens. 2004. PMID: 15614017 Review. No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
